Tumor cell invasion of collagen matrices requires coordinate lipid agonist-induced G-protein and membrane-type matrix metalloproteinase-1-dependent signaling

Molecular Cancer

Volumn 5, Issue , 2006, Pages

  Fisher, Kevin E ^a,b   Pop, Andreia ^a   Koh, Wonshill ^a,b   Anthis, Nicholas J ^a   Saunders, W Brian ^a   Davis, George E ^a,b  

^a TEXAS A AND M HEALTH SCIENCE CENTER   (United States)

^b University of Missouri   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGEN; COMPLEMENTARY DNA; GUANINE NUCLEOTIDE BINDING PROTEIN; INTERSTITIAL COLLAGENASE; LIPID; LYSOPHOSPHATIDIC ACID; MATRIX METALLOPROTEINASE INHIBITOR; RHO GUANINE NUCLEOTIDE BINDING PROTEIN; SMALL INTERFERING RNA; SPHINGOSINE 1 PHOSPHATE; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TISSUE INHIBITOR OF METALLOPROTEINASE 2; TISSUE INHIBITOR OF METALLOPROTEINASE 3; TISSUE INHIBITOR OF METALLOPROTEINASE 4; DRUG DERIVATIVE; LYSOPHOSPHATIDIC ACID RECEPTOR; LYSOPHOSPHOLIPID; MATRIX METALLOPROTEINASE; MATRIX METALLOPROTEINASE 14; PROTEIN CDC42; RAC1 PROTEIN; SPHINGOSINE; SPHINGOSINE 1 PHOSPHATE RECEPTOR; SPHINGOSINE 1-PHOSPHATE;

ARTICLE; CANCER CELL CULTURE; CELL INVASION; CELL MIGRATION; CELL MOTILITY; CELL STRAIN HEK293; CONTROLLED STUDY; FIBROSARCOMA; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; TUMOR CELL; WESTERN BLOTTING; ZYMOGRAPHY; BIOLOGICAL MODEL; CANCER INVASION; CELL MOTION; DRUG EFFECT; DRUG POTENTIATION; EXTRACELLULAR MATRIX; METABOLISM; NEOPLASM; PATHOLOGY; PHYSIOLOGY; SIGNAL TRANSDUCTION; TIME; TUMOR CELL CULTURE;

CDC42 GTP-BINDING PROTEIN; CELL MOVEMENT; COLLAGEN; EXTRACELLULAR MATRIX; GTP-BINDING PROTEINS; HUMANS; LIPIDS; LYSOPHOSPHOLIPIDS; MATRIX METALLOPROTEINASE 14; MATRIX METALLOPROTEINASES; MODELS, BIOLOGICAL; NEOPLASM INVASIVENESS; NEOPLASMS; RAC1 GTP-BINDING PROTEIN; RECEPTORS, LYSOPHOSPHATIDIC ACID; RECEPTORS, LYSOSPHINGOLIPID; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION; SPHINGOSINE; TIME FACTORS; TUMOR CELLS, CULTURED;

EID: 33846689213     PISSN: None     EISSN: 14764598     Source Type: Journal    
DOI: 10.1186/1476-4598-5-69     Document Type: Article

References (73)

1. Stetler-Stevenson WG Aznavoorian S Liotta LA Tumor cell interactions with the extracellular matrix during invasion and metastasis Annu Rev Cell Biol 1993 9(1)541-573 10.1146/annurev.cb.09.110193.002545 8280471
2. Mignatti P Rifkin DB Biology and biochemistry of proteinases in tumor invasion Physiol Rev 1993 73(1) 161-195 8419965
3. Friedl P Wolf K Tumour-cell invasion and migration: Diversity and escape mechanisms Nat Rev Cancer 2003 3(5) 362-374 10.1038/nrc1075 12724734
4. Gehlsen KR Davis GE Sriramarao P Integrin expression in human melanoma cells with differing invasive and metastatic properties Clin Exp Metastasis 1992 10(2) 111-120 10.1007/BF00114587 1311225
5. Sabeh F Ota I Holmbeck K Birkedal-Hansen H Soloway P Balbin M Lopez-Otin C Shapiro S Inada M Krane S Allen E Chung D Weiss SJ Tumor cell traffic through the extracellular matrix is controlled by the membrane-anchored collagenase MT1-MMP J Cell Biol 2004 167(4) 769-781 10.1083/ jcb.200408028 15557125
6. Seiki M Membrane-type 1 matrix metalloproteinase: A key enzyme for tumor invasion Cancer Lett 2003 194 (1) 1-11 10.1016/S0304-3835(02)00699-7 12706853
7. Chambers AF Groom AC MacDonald IC Dissemination and growth of cancer cells in metastatic sites Nat Rev Cancer 2002 2(8) 563-572 10.1038/ nrc865 12154349
8. Ridley AJ Schwartz MA Burridge K Firtel RA Ginsberg MH Borisy G Parsons JT Horwitz AR Cell migration: Integrating signals from front to back Science 2003 302 (5651) 1704-1709 10.1126/science.1092053 14657486
9. Hanahan D Weinberg RA The Hallmarks of Cancer Cell 2000 100(1) 57-70 10.1016/S0092-8674(00)81683-9 10647931
10. Sporn MB The war on cancer The Lancet 1996 347(9012) 1377-1381 10.1016/ S0140-6736(96)91015-6
11. Hla T Signaling and biological actions of sphingosine 1-phosphate Pharmacol Res 2003 47(5) 401-407 10.1016/S1043-6618(03)00046-X 12676514
12. Goetzl EJ Wang W McGiffert C Huang MC Graler MH Sphingosine 1-phosphate and its G protein-coupled receptors constitute a multifunctional immunoregulatory system J Cell Biochem 2004 92(6) 1104-1114 1557660 15258896 10.1002/jcb.20053
13. Lee H Goetzl EJ An S Lysophosphatidic acid and sphingosine 1-phosphate stimulate endothelial cell wound healing Am J Physiol Cell Physiol 2000 278(3) C612-C618 10712250
14. Saba JD Lysophospholipids in development: Miles apart and edging in J Cell Biochem 2004 92(5) 967-992 10.1002/jcb.20128 15258919
15. Panetti TS Differential effects of sphingosine 1-phosphate and lysophosphatidic acid on endothelial cells Biochim Biophys Acta 2002 1582(1-3) 190-196 12069828
16. Kluk MJ Hla T Signaling of sphingosine-1-phosphate via the S1P/ EDG-family of G-protein-coupled receptors Biochim Biophys Acta 2002 1582(1-3) 72-80 12069812
17. Whitehead IP Zohn IE Der CJ Rho GTPase-dependent transformation by G protein-coupled receptors Oncogene 2001 20(13) 1547-1555 10.1038/ sj.onc.1204188 11313901
18. Moolenaar WH Bioactive lysophospholipids and their G protein-coupled receptors Exp Cell Res 1999 253(1) 230-238 10.1006/excr.1999.4702 10579925
19. Moolenaar WH Lysophosphatidic Acid, a Multifunctional Phospholipid Messenger J Biol Chem 1995 270(22) 12949-12952 7768880
20. Kostenis E Novel clusters of receptors for sphingosine-1-phosphate, sphingosylphosphorylcholine, and (lyso)-phosphatidic acid: New receptors for "old" ligands J Cell Biochem 2004 92(5) 923-936 10.1002/ jcb.20092 15258916
21. Spiegel S Milstien S Sphingosine-1-phosphate: An enigmatic signalling lipid Nat Rev Mol Cell Biol 2003 4(5) 397-407 10.1038/nrm1103 12728273
22. Umezu-Goto M Kishi Y Taira A Hama K Dohmae N Takio K Yamori T Mills GB Inoue K Aoki J Arai H Autotaxin has lysophospholipase D activity leading to tumor cell growth and motility by lysophosphatidic acid production J Cell Biol 2002 158 (2) 227-233 10.1083/jcb.200204026 12119361
23. Mills GB Eder A Fang X Hasegawa Y Mao M Lu Y Tanyi J Tabassam FH Wiener J Lapushin R Yu S Parrott JA Compton T Tribley W Fishman D Stack MS Gaudette D Jaffe R Furui T Aoki J Erickson JR Critical role of lysophospholipids in the pathophysiology, diagnosis, and management of ovarian cancer Cancer Treat Res 2002 107 259-283 11775454
24. Fishman DA Liu Y Ellerbroek SM Stack MS Lysophosphatidic acid promotes matrix metalloproteinase (MMP) activation and MMP-dependent invasion in ovarian cancer cells Cancer Res 2001 61(7) 3194-3199 11306508
25. Mills GB Moolenaar WH The emerging role of lysophosphatidic acid in cancer Nat Rev Cancer 2003 3(8) 582-591 10.1038/nrc1143 12894246
26. Milstien S Spiegel S Targeting sphingosine-1-phosphate: A novel avenue for cancer therapeutics Cancer Cell 2006 9(3) 148-150 10.1016/ j.ccr.2006.02.025 16530698
27. Moolenaar WH van Meeteren LA Giepmans BN The ins and outs of lysophosphatidic acid signaling Bioessays 2004 26(8) 870-881 10.1002/ bies.20081 15273989
28. Bayless KJ Davis GE Sphingosine 1-phosphate markedly induces matrix metalloproteinase and integrin-dependent human endothelial cell invasion and lumen formation in three-dimensional collagen and fibrin matrices Biochem Biophys Res Commun 2003 312(4) 903-913 10.1016/ j.bbrc.2003.11.017 14651957
29. Langlois S Gingras D Beliveau R Membrane type 1-matrix metalloproteinase (MT1-MMP) cooperates with sphingosine 1-phosphate to induce endothelial cell migration and morphogenic differentiation Blood 2004 103(8) 3020-3028 10.1182/blood-2003-08-2968 15070679
30. Stetler-Stevenson WG Yu AE Proteases in invasion: Matrix metalloproteinases Semin Cancer Biol 2001 11(2) 143-152 10.1006/ scbi.2000.0365 11322833
31. Egeblad M Werb Z New functions for the matrix metalloproteinases in cancer progression Nat Rev Cancer 2002 2(3) 161-174 10.1038/nrc745 11990853
32. Foda HD Zucker S Matrix metalloproteinases in cancer invasion, metastasis and angiogenesis Drug Discov Today 2001 6(9) 478-482 10.1016/ S1359-6446(01)01752-4 11344033
33. Itoh Y Nagase H Matrix metalloproteinases in cancer Essays Biochem 2002 38 21-36 12463159
34. Vihinen P Ala-aho R Kahari VM Matrix metalloproteinases as therapeutic targets in cancer Curr Cancer Drug Targets 2005 5(3) 203-220 10.2174/ 1568009053765799 15892620
35. Coussens LM Fingleton B Matrisian LM Matrix metalloproteinase inhibitors and cancer: Trials and tribulations Science 2002 295(5564) 2387-2392 10.1126/science.1067100 11923519
36. Ohuchi E Imai K Fujii Y Sato H Seiki M Okada Y Membrane type 1 matrix metalloproteinase digests interstitial collagens and other extracellular matrix macromolecules J Biol Chem 1997 272(4) 2446-2451 10.1074/ jbc.272.4.2446 8999957
37. Hotary K Allen E Punturieri A Yana I Weiss SJ Regulation of cell invasion and morphogenesis in a three-dimensional type I collagen matrix by membrane-type matrix metalloproteinases 1, 2, and 3 J Cell Biol 2000 149(6) 1309-1323 10.1083/jcb.149.6.1309 10851027
38. Yana I Seiki M MT-MMPs play pivotal roles in cancer dissemination Clin Exp Metastasis 2002 19(3) 209-215 10.1023/A:1015527220537 12067201
39. Rozanov DV Deryugina EI Ratnikov BI Monosov EZ Marchenko GN Quigley JP Strongin AY Mutation analysis of membrane type-1 matrix metalloproteinase (MT1-MMP). The role of the cytoplasmic tail Cys(574), the active site Glu(240), and furin cleavage motifs in oligomerization, processing, and self-proteolysis of MT1-MMP expressed in breast carcinoma cells J Biol Chem 2001 276(28) 25705-25714 10.1074/ jbc.M007921200 11335709
40. Davis GE Senger DR Endothelial extracellular matrix: Biosynthesis, remodeling, and functions during vascular morphogenesis and neovessel stabilization Circ Res 2005 97(11) 1093-1107 10.1161/ 01.RES.0000191547.64391.e3 16306453
41. Peterson H Reeves B Brown R Hall A Furth M Bos J Jones P Marshall C Activated N-ras Controls the Transformed Phenotype of HT1080 Human Fibrosarcoma Cells Cell 1987 51 803-812 10.1016/0092-8674(87)90103-6 3315232
42. Rasheed S Nelson Rees WA Toth EM Arnstein P Gardner MB Characterisation of a newly derived human sarcoma cell line (HT1080) Cancer 1974 33(4) 1027-1033 10.1002/ 1097-0142(197404)33:4<1027::AID-CNCR2820330419>3.0.CO;2-Z 4132053
43. Siehler S Manning DR Pathways of transduction engaged by sphingosine 1-phosphate through G protein-coupled receptors Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids 2002 1582(1-3) 94-99 10.1016/S1388-1981(02)00142-7
44. Ye X Ishii I Kingsbury MA Chun J Lysophosphatidic acid as a novel cell survival/apoptotic factor Biochim Biophys Acta 2002 1585 (2-3) 108-113 12531543
45. Price LS Collard JG Regulation of the cytoskeleton by Rho-family GTPases: Implications for tumour cell invasion Semin Cancer Biol 2001 11(2) 167-173 10.1006/scbi.2000.0367 11322835
46. Schmitz AA Govek EE Bottner B Van Aelst L Rho GTPases: Signaling, migration, and invasion Exp Cell Res 2000 261(1) 1-12 10.1006/ excr.2000.5049 11082269
47. Okamoto H Takuwa N Yokomizo T Sugimoto N Sakurada S Shigematsu H Takuwa Y Inhibitory regulation of Rac activation, membrane ruffling, and cell migration by the G protein-coupled sphingosine-1-phosphate receptor EDG5 but not EDG1 or EDG3 Mol Cell Biol 2000 20(24) 9247-9261 102182 11094076 10.1128/MCB.20.24.9247-9261.2000
48. Radeff-Huang J Seasholtz TM Matteo RG Brown JH G protein mediated signaling pathways in lysophospholipid induced cell proliferation and survival J Cell Biochem 2004 92 5 949-966 10.1002/jcb.20094 15258918
49. Wolf K Mazo I Leung H Engelke K von Andrian UH Deryugina EI Strongin AY Brocker EB Friedl P Compensation mechanism in tumor cell migration: mesenchymal-amoeboid transition after blocking of pericellular proteolysis J Cell Biol 2003 160(2) 267-277 10.1083/jcb.200209006 12527751
50. Nabeshima K Inoue T Shimao Y Sameshima T Matrix metalloproteinases in tumor invasion: Role for cell migration Pathol Int 2002 52(4) 255-264 10.1046/j.1440-1827.2002.01343.x 12031080
51. Seiki M Mori H Kajita M Uekita T Itoh Y Membrane-type 1 matrix metalloproteinase and cell migration Biochem Soc Symp 2003 253-262 14587298
52. Visse R Nagase H Matrix metalloproteinases and tissue inhibitors of metalloproteinases: Structure, function, and biochemistry Circ Res 2003 92(8) 827-839 10.1161/01.RES.0000070112.80711.3D 12730128
53. Lambert E Dasse E Haye B Petitfrere E TIMPs as multifacial proteins Crit Rev Oncol Hematol 2004 49(3) 187-198 15036259
54. Hotary KB Allen ED Brooks PC Datta NS Long MW Weiss SJ Membrane type I matrix metalloproteinase usurps tumor growth control imposed by the three-dimensional extracellular matrix Cell 2003 114(1) 33-45 10.1016/ S0092-8674(03)00513-0 12859896
55. Cukierman E Pankov R Yamada KM Cell interactions with three-dimensional matrices Current Opinion in Cell Biology 2002 14(5) 633-640 10.1016/ S0955-0674(02)00364-2 12231360
56. Xu Y Shen Z Wiper DW Wu M Morton RE Elson P Kennedy AW Belinson J Markman M Casey G Lysophosphatidic acid as a potential biomarker for ovarian and other gynecologic cancers JAMA 1998 280(8) 719-723 10.1001/ jama.280.8.719 9728644
57. Clair T Aoki J Koh E Bandle RW Nam SW Ptaszynska MM Mills GB Schiffmann E Liotta LA Stracke ML Autotaxin hydrolyzes sphingosylphosphorylcholine to produce the regulator of migration, sphingosine-1-phosphate Cancer Res 2003 63(17) 5446-5453 14500380
58. Tokumura A Majima E Kariya Y Tominaga K Kogure K Yasuda K Fukuzawa K Identification of human plasma lysophospholipase D, a lysophosphatidic acid-producing enzyme, as autotaxin, a multifunctional phosphodiesterase J Biol Chem 2002 277(42) 39436-39442 10.1074/jbc.M205623200 12176993
59. Yamada T Sato K Komachi M Malchinkhuu E Tobo M Kimura T Kuwabara A Yanagita Y Ikeya T Tanahashi Y Ogawa T Ohwada S Morishita Y Ohta H Im DS Tamoto K Tomura H Okajima F Lysophosphatidic acid (LPA) in malignant ascites stimulates motility of human pancreatic cancer cells through LPA1 J Biol Chem 2004 279(8) 6595-6605 10.1074/jbc.M308133200 14660630
60. Saba JD Hla T Point-counterpoint of sphingosine 1-phosphate metabolism Circ Res 2004 94(6) 724-734 10.1161/01.RES.0000122383.60368.24 15059942
61. van Meeteren LA Ruurs P Christodoulou E Goding JW Takakusa H Kikuchi K Perrakis A Nagano T Moolenaar WH Inhibition of autotaxin by lysophosphatidic acid and sphingosine 1-phosphate J Biol Chem 2005 280(22) 21155-21161 10.1074/jbc.M413183200 15769751
62. Stadler CR Knyazev P Bange J Ullrich A FGFR4 GLY388 isotype suppresses motility of MDA-MB-231 breast cancer cells by EDG-2 gene repression Cell Signal 2006 18(6) 783-794 10.1016/j.cellsig.2005.07.002 16109476
63. Deryugina EI Zijlstra A Partridge JJ Kupriyanova TA Madsen MA Papagiannakopoulos T Quigley JP Unexpected effect of matrix metalloproteinase down-regulation on vascular intravasation and metastasis of human fibrosarcoma cells selected in vivo for high rates of dissemination Cancer Res 2005 65(23) 10959-10969 10.1158/ 0008-5472.CAN-05-2228 16322244
64. Visentin B Vekich JA Sibbald BJ Cavalli AL Moreno KM Matteo RG Garland WA Lu Y Yu S Hall HS Kundra V Mills GB Sabbadini RA Validation of an anti-sphingosine-1-phosphate antibody as a potential therapeutic in reducing growth, invasion, and angiogenesis in multiple tumor lineages Cancer Cell 2006 9(3) 225-238 10.1016/j.ccr.2006.02.023 16530706
65. Coussens LM Tinkle CL Hanahan D Werb Z MMP-9 supplied by bone marrow-derived cells contributes to skin carcinogenesis Cell 2000 103(3) 481-490 10.1016/S0092-8674(00)00139-2 11081634
66. Schnaeker EM Ossig R Ludwig T Dreier R Oberleithner H Wilhelmi M Schneider SW Microtubule-dependent matrix metalloproteinase-2/matrix metalloproteinase-9 exocytosis: Prerequisite in human melanoma cell invasion Cancer Res 2004 64(24) 8924-8931 10.1158/0008-5472.CAN-04-0324 15604254
67. Wu WT Chen CN Lin CI Chen JH Lee H Lysophospholipids enhance matrix metalloproteinase-2 expression in human endothelial cells Endocrinology 2005 146(8) 3387-3400 10.1210/en.2004-1654 15878967
68. Bornstein MB Reconstituted rat-tail collagen used as a substrate for tissue cultures on coverslips in Maximov slides and rollertubes Lab Invest 1958 7 134-137 13540204
69. Bayless KJ Davis GE The Cdc42 and Rac1 GTPases are required for capillary lumen formation in three-dimensional extracellular matrices J Cell Sci 2002 115(6) 1123-1136 11884513
70. Salazar R Bell SE Davis GE Coordinate induction of the actin cytoskeletal regulatory proteins gelsolin, vasodilator-stimulated phosphoprotein, and profilin during capillary morphogenesis in vitro Exp Cell Res 1999 249(1) 22-32 10.1006/excr.1999.4460 10328950
71. Davis GE Camarillo CW An alpha 2 beta 1 integrin-dependent pinocytic mechanism involving intracellular vacuole formation and coalescence regulates capillary lumen and tube formation in three-dimensional collagen matrix Exp Cell Res 1996 224(1) 39-51 10.1006/excr.1996.0109 8612690
72. Saunders WB Bayless KJ Davis GE MMP-1 activation by serine proteases and MMP-10 induces human capillary tubular network collapse and regression in 3D collagen matrices J Cell Sci 2005 118(Pt 10) 2325-2340 10.1242/ jcs.02360 15870107
73. He TC Zhou S da Costa LT Yu J Kinzler KW Vogelstein B A simplified system for generating recombinant adenoviruses PNAS 1998 95(5) 2509-2514 19394 9482916 10.1073/pnas.95.5.2509